# CLOBAZAM
> **ANDA209796** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2020-02-24
## Drug
- **FDA Application Number:** ANDA209796
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CLOBAZAM
- **Generic name:** CLOBAZAM
- **Active ingredients:** CLOBAZAM
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD III
- **Manufacturer:** NorthStar RxLLC
- **First approval:** 2020-02-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209796)
---
*MORVS · CC0 1.0*